Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Ensuring Compliance with Stability Guidelines – V 2.0

Posted on By

SOP for Ensuring Compliance with Stability Guidelines – V 2.0

Procedure for Ensuring Compliance with Stability Guidelines

Department Quality Assurance (QA)/Quality Control (QC)/Regulatory Affairs
SOP No. SOP/Ointment/109
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a standardized approach for ensuring compliance with stability study guidelines, including ICH Q1A(R2), WHO GMP, and local regulatory requirements. This ensures the reliability of stability data and regulatory adherence.

2. Scope

This SOP applies to all personnel in the Quality Assurance (QA), Quality Control (QC), and Regulatory Affairs departments responsible for planning, executing, and monitoring stability studies.

3. Responsibilities

  • QA Manager: Ensures compliance with stability testing guidelines and oversees study protocols.
  • QC Analyst: Conducts stability testing as per approved protocols.
  • Regulatory Affairs Officer: Reviews stability data for submission to regulatory agencies.
  • QC Supervisor: Ensures adherence to predefined study conditions and protocol compliance.
  • QA Officer: Verifies accuracy, consistency, and completeness of stability records.
See also  Ointments: SOP for Documentation of Packed Batches - V 2.0

4. Accountability

The QA and Regulatory Affairs Managers are accountable for ensuring compliance with ICH, WHO, and local regulatory guidelines for stability testing.

5. Procedure

5.1 Regulatory Compliance and Guidelines

  • Ensure all stability studies comply with ICH Q1A(R2) and WHO stability testing guidelines.
  • Confirm adherence to local regulatory agency requirements (e.g., US FDA, EMA, CDSCO).
  • Review
stability study protocols to align with regulatory expectations.

5.2 Stability Study Design and Execution

  • Design stability studies based on product formulation and packaging type.
  • Define testing conditions as per regulatory standards:
    • Long-term stability: 25°C ± 2°C / 60% RH ± 5% RH
    • Intermediate stability: 30°C ± 2°C / 65% RH ± 5% RH
    • Accelerated stability: 40°C ± 2°C / 75% RH ± 5% RH
  • Ensure appropriate sample storage and periodic testing as per protocol.

5.3 Data Documentation and Integrity

  • Maintain stability data in compliance with ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate) principles.
  • Ensure real-time documentation of all observations and deviations.
  • Retain raw data and reports for regulatory audits and inspections.

5.4 Handling Deviations and Out-of-Specification (OOS) Results

  • Investigate any deviations from predefined stability criteria.
  • Document OOS results in the Stability Deviation Log.
  • Perform root cause analysis and implement corrective and preventive actions (CAPA).

5.5 Periodic Review and Compliance Monitoring

  • Conduct periodic stability study audits to verify regulatory adherence.
  • Review and update stability protocols based on new guidelines or regulatory changes.
  • Ensure stability reports are submitted to regulatory authorities in a timely manner.

6. Abbreviations

  • GMP – Good Manufacturing Practices
  • QA – Quality Assurance
  • QC – Quality Control
  • ICH – International Council for Harmonisation
  • RH – Relative Humidity
  • OOS – Out-of-Specification
  • CAPA – Corrective and Preventive Action
  • ALCOA+ – Attributable, Legible, Contemporaneous, Original, Accurate

7. Documents

  • Stability Compliance Checklist (Annexure-1)
  • Regulatory Compliance Report (Annexure-2)

8. References

  • ICH Q1A(R2) Stability Testing of New Drug Substances and Products
  • WHO GMP Guidelines for Pharmaceutical Stability Studies
  • US FDA and EMA Stability Testing Requirements

9. SOP Version

Version 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Stability Compliance Checklist

Compliance Area Requirement Status Reviewed By
ICH Q1A(R2) Guidelines Stability conditions followed Compliant QA Officer
WHO GMP Compliance Study aligns with GMP Compliant QA Officer

Annexure-2: Regulatory Compliance Report

Batch Number Testing Condition Regulatory Requirement Compliance Status Reviewed By
OINT-901 Long-Term Stability ICH Q1A(R2) Compliant QA Manager
OINT-902 Accelerated Stability WHO GMP Compliant QA Manager

12. Revision History:

Revision Date Revision No. Details of Revision Reason for Revision Approved By
01/01/2024 1.0 Initial Version New SOP QA Head
01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
See also  Ointments: SOP for Maintaining QA Approval Logs - V 2.0
Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

Post navigation

Previous Post: SOP for Transporting Rejected Raw Materials from Quarantine to Disposal Area – V 2.0
Next Post: Creams: SOP for Cross-Verification of Weighed Materials – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version